Rasburicase (Fasturtec) Registration Trial

NCT00607152 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped the patient enrollment is too difficult

Conditions

Hyperuricemia

Interventions

DRUG: Rasburicase
DRUG: Allopurinol

Sponsor

Sanofi